Alpha 2.0
Login Register
» Articles » PMID: 31543365

Recurrence After Robotic Retroperitoneal Lymph Node Dissection Raises More Questions Than Answers

Overview
Journal Eur Urol
Specialty Urology
Date 2019 Sep 24
PMID 31543365
Citations 3
Authors
James Porter
Scott Eggener
Erik Castle
Phillip Pierorazio
Affiliations
Soon will be listed here.
Citing Articles

Clinical efficacy and safety of robotic retroperitoneal lymph node dissection for testicular cancer: a systematic review and meta-analysis.

Yuan Y, Zhang D, Ning Y, Luo H, Qiu X, Tan Y Front Oncol. 2024; 13:1257528.

PMID: 38169835 PMC: 10758414. DOI: 10.3389/fonc.2023.1257528.

Robot-assisted retroperitoneal lymph node dissection for post-chemotherapy residual mass in testicular cancer: Long-term experience from a tertiary care centre.

Vasudeo V, Khanna A, Pratihar S, Jaipuria J, Chakraborty A, Rawal S J Minim Access Surg. 2023; 19(2):288-295.

PMID: 36629220 PMC: 10246628. DOI: 10.4103/jmas.jmas_141_22.

Robotic RPLND for stage IIA/B nonseminoma: the Princess Margaret Experience.

Nason G, Hamilton R World J Urol. 2022; 40(2):335-342.

PMID: 34988650 DOI: 10.1007/s00345-021-03899-9.